You are here
A guide to selecting targeted therapy
In this infographic, we review the definition of severe uncontrolled asthma, discuss the steps toward accurately assessing and diagnosing patients with eosinophilic asthma, and introduce a selection of interleukin 5 (IL-5) biologicals for the targeting of airway inflammation.
Following the infographic, participants should be able to:
- Recognize the importance of early management and the need for a personalized approach when treating patients with eosinophilic asthma
- Define severe uncontrolled asthma
- Discuss clinical criteria used to accurately assess and diagnose eosinophilic status
- List the different emerging therapies targeting the IL-5 pathway in eosinophilic asthma